Burgetová Ječmeňová Kateřina

Academic title: Mgr.

E-mail: katerina.jecmenova01@upol.cz

Groups: BACHELOR STUDENT, DOCTORAL STUDENT, IMTM, LEM, MASTER STUDENT, STAFF

Curriculum vitae

Drug resistance mechanisms in cancer

Specialization: Pediatrics

Supervisor: Džubák Petr M.D., Ph.D.

Status: Ongoing from 2020.

Development and characterization of resistant cell lines to purine and pyrimidine cytotoxic drugs

Supervisor: Džubák Petr M.D., Ph.D.

Status: Graduated from 2018 to 2020.

Spectroscopic characteristics used drugs and their use in the identification of molecular targets

Supervisor: Stanková Jarmila

Status: Graduated from 2016 to 2018.

Ph.D. candidate specializing in molecular and cell biology, with a primary research focus on identifying and characterizing modulators of G protein-coupled receptors (GPCRs), particularly adenosine receptor agonists and antagonists. Possesses practical experience in cancer cell biology, molecular biology techniques, and high-throughput screening methodologies.

SINKEVICIUTE, U., K. BURGETOVÁ JEČMEŇOVÁ, S. GURSKÁ, L. POSTOVA SLAVETINSKA, V. BARAN, P. POLISHCHUK, P. DŽUBÁK, M. HOCEK, M. HAJDÚCH, M. TICHÝ

Synthesis and Biological Activity of 2,6-Disubstituted and 2,6,9-Trisubstituted 7-Deazapurine Nucleobases. ChemMedChem. 2026, 21(16), e70419, ISSN: 1860-7179, PMID: 42596056, PDF.

JURÁŠEK, M., E. DRABEROVA, J. ŘEHULKA, S. GURSKÁ, A. IVANOVA (NIKONENKO), P. POLISHCHUK, K. BURGETOVÁ JEČMEŇOVÁ, J. FAHNRICH, A. MARESOVA, J. TAUCHEN, A. REYES ROMERO, A. DÖMLING, M. HAJDÚCH, P. DRAŠAR, P. DRABER, P. DŽUBÁK

Colchicine-BODIPY Probes: Evidence for the Involvement of Intracellular Membranes in the Targeting of Colchicine to Tubulin. ACS pharmacology & translational science. 2025, 8(7), 1965-1985, ISSN: 2575-9108, PMID: 40672674, PDF.

ŘEHULKA, J., M. JURÁŠEK, P. DRABER, A. IVANOVA (NIKONENKO), S. GURSKÁ, K. BURGETOVÁ JEČMEŇOVÁ, O. MOKSHYNA, M. HAJDÚCH, P. POLISHCHUK, P. DRAŠAR, P. DŽUBÁK

Click estradiol dimers with novel aromatic bridging units: synthesis and anticancer evaluation. Journal of enzyme inhibition and medicinal chemistry. 2024, 39(1), 2367139, ISSN: 1475-6366 , PMID: 38904149, PDF.

Fialová Kateřina

siRNA knock-down of A3 adenosine receptor

Status: Ongoing from 2022.

Burgetová Ječmeňová Kateřina

Doctoral training

Master training

Bachelor training

About me

Journals

Bachelor mentorship

Fialová Kateřina